Page last updated: 2024-08-23

1-deoxynojirimycin and Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency

1-deoxynojirimycin has been researched along with Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byers, S; Derrick-Roberts, A; Fletcher, J; Kaidonis, X; Ranieri, E; Sharp, P	1
Bin-Dorel, S; Decullier, E; Fouilhoux, A; Guffon, N; Guitton, J; Paillet, C	1
Jakóbkiewicz-Banecka, J; Wegrzyn, A; Wegrzyn, G	1

Reviews

1 review(s) available for 1-deoxynojirimycin and Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency

Article	Year
Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. Journal of applied genetics, 2007, Volume: 48, Issue:4 Topics: 1-Deoxynojirimycin; Animals; Enzyme Inhibitors; Gaucher Disease; Genistein; Humans; Lysosomal Storage Diseases; Lysosomes; Mucopolysaccharidosis III; Niemann-Pick Diseases; Sandhoff Disease; Tay-Sachs Disease	2007

Article

Year

Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.

Journal of applied genetics, 2007, Volume: 48, Issue:4

Topics: 1-Deoxynojirimycin; Animals; Enzyme Inhibitors; Gaucher Disease; Genistein; Humans; Lysosomal Storage Diseases; Lysosomes; Mucopolysaccharidosis III; Niemann-Pick Diseases; Sandhoff Disease; Tay-Sachs Disease

2007

Trials

1 trial(s) available for 1-deoxynojirimycin and Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency

Article	Year
Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study. The Journal of pediatrics, 2011, Volume: 159, Issue:5 Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Brain; Child; Child, Preschool; Cognition; Double-Blind Method; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Magnetic Resonance Imaging; Male; Mucopolysaccharidosis III; Neuropsychological Tests; Sleep Wake Disorders	2011

Article

Year

Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study.

The Journal of pediatrics, 2011, Volume: 159, Issue:5

Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Brain; Child; Child, Preschool; Cognition; Double-Blind Method; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Magnetic Resonance Imaging; Male; Mucopolysaccharidosis III; Neuropsychological Tests; Sleep Wake Disorders

2011

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency

Article	Year
N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice. Molecular genetics and metabolism, 2016, Volume: 118, Issue:2 Topics: 1-Deoxynojirimycin; Analysis of Variance; Animals; Brain; Chemokine CCL3; Disease Models, Animal; Fear; Gangliosides; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Interleukin-1beta; Maze Learning; Mice; Mucopolysaccharidosis III	2016

Article

Year

N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice.

Molecular genetics and metabolism, 2016, Volume: 118, Issue:2

Topics: 1-Deoxynojirimycin; Analysis of Variance; Animals; Brain; Chemokine CCL3; Disease Models, Animal; Fear; Gangliosides; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Interleukin-1beta; Maze Learning; Mice; Mucopolysaccharidosis III

2016